Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis

The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expre...

Full description

Saved in:
Bibliographic Details
Published inExperimental hematology Vol. 40; no. 9; pp. 771 - 780.e19
Main Authors Skov, Vibe, Thomassen, Mads, Riley, Caroline H., Jensen, Morten K., Bjerrum, Ole Weis, Kruse, Torben A., Hasselbalch, Hans Carl, Larsen, Thomas Stauffer
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expression profiling of whole blood from control subjects (n = 21) and patients with ET (n = 19), PV (n = 41), and PMF (n = 9) using DNA microarrays. Applying an unsupervised method, principal component analysis, to search for patterns in the data, we demonstrated a separation of the four groups with biological relevant overlaps between the different entities. Moreover, the analysis separates Janus activating kinase 2-negative ET patients from Janus activating kinase 2-positive ET patients. Functional annotation analysis demonstrates that clusters of gene ontology terms related to inflammation, immune system, apoptosis, RNA metabolism, and secretory system were the most significantly deregulated terms in the three different disease groups. Our results yield further support for the hypothesis of a biological continuum originating from ET over PV to PMF. Functional analysis suggests an important implication of these gene ontology clusters in the pathogenesis of these neoplasms and in disease evolution from ET over PV to PMF.
AbstractList The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expression profiling of whole blood from control subjects (n = 21) and patients with ET (n = 19), PV (n = 41), and PMF (n = 9) using DNA microarrays. Applying an unsupervised method, principal component analysis, to search for patterns in the data, we demonstrated a separation of the four groups with biological relevant overlaps between the different entities. Moreover, the analysis separates Janus activating kinase 2-negative ET patients from Janus activating kinase 2-positive ET patients. Functional annotation analysis demonstrates that clusters of gene ontology terms related to inflammation, immune system, apoptosis, RNA metabolism, and secretory system were the most significantly deregulated terms in the three different disease groups. Our results yield further support for the hypothesis of a biological continuum originating from ET over PV to PMF. Functional analysis suggests an important implication of these gene ontology clusters in the pathogenesis of these neoplasms and in disease evolution from ET over PV to PMF.
The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expression profiling of whole blood from control subjects (n = 21) and patients with ET (n = 19), PV (n = 41), and PMF (n = 9) using DNA microarrays. Applying an unsupervised method, principal component analysis, to search for patterns in the data, we demonstrated a separation of the four groups with biological relevant overlaps between the different entities. Moreover, the analysis separates Janus activating kinase 2-negative ET patients from Janus activating kinase 2-positive ET patients. Functional annotation analysis demonstrates that clusters of gene ontology terms related to inflammation, immune system, apoptosis, RNA metabolism, and secretory system were the most significantly deregulated terms in the three different disease groups. Our results yield further support for the hypothesis of a biological continuum originating from ET over PV to PMF. Functional analysis suggests an important implication of these gene ontology clusters in the pathogenesis of these neoplasms and in disease evolution from ET over PV to PMF.The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expression profiling of whole blood from control subjects (n = 21) and patients with ET (n = 19), PV (n = 41), and PMF (n = 9) using DNA microarrays. Applying an unsupervised method, principal component analysis, to search for patterns in the data, we demonstrated a separation of the four groups with biological relevant overlaps between the different entities. Moreover, the analysis separates Janus activating kinase 2-negative ET patients from Janus activating kinase 2-positive ET patients. Functional annotation analysis demonstrates that clusters of gene ontology terms related to inflammation, immune system, apoptosis, RNA metabolism, and secretory system were the most significantly deregulated terms in the three different disease groups. Our results yield further support for the hypothesis of a biological continuum originating from ET over PV to PMF. Functional analysis suggests an important implication of these gene ontology clusters in the pathogenesis of these neoplasms and in disease evolution from ET over PV to PMF.
The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential thrombocythemia (ET) and primary myelofibrosis (PMF) has favored the hypothesis of a biological continuum from ET over PV to PMF. We performed gene expression profiling of whole blood from control subjects (n = 21) and patients with ET (n = 19), PV (n = 41), and PMF (n = 9) using DNA microarrays. Applying an unsupervised method, principal component analysis, to search for patterns in the data, we demonstrated a separation of the four groups with biological relevant overlaps between the different entities. Moreover, the analysis separates Janus activating kinase 2-negative ET patients from Janus activating kinase 2-positive ET patients. Functional annotation analysis demonstrates that clusters of gene ontology terms related to inflammation, immune system, apoptosis, RNA metabolism, and secretory system were the most significantly deregulated terms in the three different disease groups. Our results yield further support for the hypothesis of a biological continuum originating from ET over PV to PMF. Functional analysis suggests an important implication of these gene ontology clusters in the pathogenesis of these neoplasms and in disease evolution from ET over PV to PMF.
Author Hasselbalch, Hans Carl
Kruse, Torben A.
Skov, Vibe
Riley, Caroline H.
Bjerrum, Ole Weis
Jensen, Morten K.
Larsen, Thomas Stauffer
Thomassen, Mads
Author_xml – sequence: 1
  givenname: Vibe
  surname: Skov
  fullname: Skov, Vibe
  email: vibe.skov@ouh.regionsyddanmark.dk
  organization: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
– sequence: 2
  givenname: Mads
  surname: Thomassen
  fullname: Thomassen, Mads
  organization: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
– sequence: 3
  givenname: Caroline H.
  surname: Riley
  fullname: Riley, Caroline H.
  organization: Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
– sequence: 4
  givenname: Morten K.
  surname: Jensen
  fullname: Jensen, Morten K.
  organization: Department of Hematology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
– sequence: 5
  givenname: Ole Weis
  surname: Bjerrum
  fullname: Bjerrum, Ole Weis
  organization: Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
– sequence: 6
  givenname: Torben A.
  surname: Kruse
  fullname: Kruse, Torben A.
  organization: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
– sequence: 7
  givenname: Hans Carl
  surname: Hasselbalch
  fullname: Hasselbalch, Hans Carl
  organization: Department of Hematology, Roskilde Hospital, University of Copenhagen, Copenhagen, Denmark
– sequence: 8
  givenname: Thomas Stauffer
  surname: Larsen
  fullname: Larsen, Thomas Stauffer
  organization: Department of Hematology, Odense University Hospital, Odense, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22659388$$D View this record in MEDLINE/PubMed
BookMark eNqVUk1v1DAQtVAR3Rb-AUI-csl2nMT5QAipqqBFqsQBkLhZjnfS9ZLYwXYK-T38UWbZ0gMSqvDFGvu95_F7c8KOnHfI2HMBawGiOtut8ce0xXGdg8jXINcgxCO2Ek1dZHnRtkdsBQWIrKzzL8fsJMYdAEjZwhN2nOeVbIumWbGfl-iQk1LAGK13fAq-t4N1N_y7TVsqrTN20gM3fpyoA5e4dnpYoo18g5M1KfK0Rd5ZP_gba34jXbJunkfeBz9yEiaWpYu0pbrzZiHCaDX3txj45Ifl_oQONE-ejwsO1EcXPL3zlD3u9RDx2d1-yj6_e_vp4iq7_nD5_uL8OjNlDSnrRNvXspeI0NVdD1LXWvbQ56Kqu67rdQUIpilbWqZqjcmxqkQuSlkaWZRNccpeHnTJg28zxqRGGw0Og3bo56gEFIUsqqasCPriDjp3I24U2TTqsKg_xhKgPAAMfSEG7O8hAtQ-P7VTh_zUPj8FUlF-RHv1F83YpBMFk4K2w0PkNwcykkm3FoOKxqIzuLEBTVIbb_9XwNAk7DP9igvGnZ8DRU9GqEgc9XE_X_vxEjmAaCpJAq__LfDw-78Asirn0g
CitedBy_id crossref_primary_10_1016_j_leukres_2015_11_017
crossref_primary_10_1080_10428194_2016_1262032
crossref_primary_10_1111_bjh_16152
crossref_primary_10_1016_j_leukres_2013_09_001
crossref_primary_10_1038_s41598_017_02655_7
crossref_primary_10_1111_ejh_12332
crossref_primary_10_3390_cancers15174323
crossref_primary_10_1016_j_leukres_2015_09_002
crossref_primary_10_3389_fimmu_2023_1117466
crossref_primary_10_1002_ccr3_281
crossref_primary_10_1038_s41467_022_32928_3
crossref_primary_10_3109_10428194_2013_764417
crossref_primary_10_1016_S0145_2126_16_30076_5
crossref_primary_10_1080_10428194_2019_1579323
crossref_primary_10_1182_blood_2014_02_554634
crossref_primary_10_1586_17474086_2015_1045409
crossref_primary_10_1016_j_leukres_2012_07_009
crossref_primary_10_1111_ejh_12684
crossref_primary_10_1016_j_leukres_2014_07_006
crossref_primary_10_1371_journal_pone_0161570
crossref_primary_10_1371_journal_pone_0112786
crossref_primary_10_1155_2015_869242
crossref_primary_10_1371_journal_pone_0135463
crossref_primary_10_1371_journal_pone_0183620
crossref_primary_10_3390_cancers12123565
crossref_primary_10_3390_cancers12082250
crossref_primary_10_1155_2015_648090
crossref_primary_10_1111_ejh_12437
crossref_primary_10_1007_s00281_018_0700_2
crossref_primary_10_1016_j_leukres_2014_04_002
crossref_primary_10_1515_sagmb_2016_0066
crossref_primary_10_3390_ijms22020561
crossref_primary_10_1007_s11136_015_1125_1
crossref_primary_10_3390_ijms22041906
crossref_primary_10_1016_j_leukres_2016_02_004
crossref_primary_10_1155_2024_1827127
crossref_primary_10_1186_s13045_017_0425_z
crossref_primary_10_1080_09537104_2024_2304173
crossref_primary_10_1371_journal_pone_0085567
crossref_primary_10_1080_17474086_2017_1284583
crossref_primary_10_1007_s12032_022_01825_6
crossref_primary_10_3109_10428194_2016_1143938
crossref_primary_10_1371_journal_pone_0270669
crossref_primary_10_1016_j_blre_2017_05_001
crossref_primary_10_1016_j_cytogfr_2013_01_004
crossref_primary_10_3390_antiox9111037
crossref_primary_10_1155_2015_102476
crossref_primary_10_1016_j_leukres_2013_07_002
crossref_primary_10_3390_cancers12071763
Cites_doi 10.1080/10428190500331329
10.1200/JCO.2009.23.6075
10.1158/0008-5472.CAN-04-1910
10.1182/blood-2008-01-134114
10.1093/nar/gkn923
10.1182/blood-2008-03-143537
10.1016/j.exphem.2005.01.015
10.3324/haematol.2010.031070
10.1016/j.exphem.2007.01.053
10.3324/haematol.2009.020412
10.1111/j.1600-0609.2007.00960.x
10.1056/NEJMra063728
10.1186/gb-2001-2-8-research0032
10.1182/blood-2005-05-1889
10.1242/jcs.03053
10.1182/blood.V6.4.372.372
10.1034/j.1600-0609.2001.00359.x
10.1046/j.1365-2141.2000.02030.x
10.1182/blood-2010-08-258772
10.2174/138920208786847971
10.1182/blood-2009-03-209544
10.1158/0008-5472.CAN-10-1731
10.1200/JCO.2010.34.5298
10.1182/blood-2009-03-209262
10.1038/sj.leu.2404209
10.1200/JCO.2004.00.9316
10.1158/1078-0432.CCR-10-1092
10.1634/stemcells.2006-0351
10.1016/0268-960X(93)90024-X
10.1182/blood-2005-12-4824
10.1182/blood-2007-08-107748
10.1038/leu.2008.357
10.1517/13543784.2011.579560
10.1111/j.1365-2141.1979.tb03739.x
10.1038/leu.2008.112
10.3109/10428194.2011.597905
10.1634/stemcells.2004-0131
10.1038/leu.2010.69
10.1111/j.1600-0609.2011.01618.x
10.1182/blood-2007-05-091850
10.1179/102453309X12473408860587
10.1182/blood-2009-05-224477
10.1016/j.leukres.2011.03.013
10.1038/nprot.2008.211
10.1097/00062752-199903000-00007
10.1016/j.exphem.2010.03.005
10.1182/blood-2010-04-279125
10.1056/NEJM199802263380902
10.1111/j.1365-2141.2007.06497.x
ContentType Journal Article
Copyright 2012 ISEH - Society for Hematology and Stem Cells
ISEH - Society for Hematology and Stem Cells
Copyright © 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2012 ISEH - Society for Hematology and Stem Cells
– notice: ISEH - Society for Hematology and Stem Cells
– notice: Copyright © 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.exphem.2012.05.011
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-2399
EndPage 780.e19
ExternalDocumentID 22659388
10_1016_j_exphem_2012_05_011
S0301472X12001865
1_s2_0_S0301472X12001865
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABCQX
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
ADVLN
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HX~
HZ~
IHE
J1W
K-O
KOM
L7B
M41
MO0
N9A
O-L
O9-
OAUVE
OC~
OO-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDH
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UDS
X7M
Y6R
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c470t-b19f75f5ee0b7bf05a7a5f0f2167bbbfa60e0c849999c69cc2e66121454c53483
IEDL.DBID .~1
ISSN 0301-472X
1873-2399
IngestDate Fri Jul 11 05:56:39 EDT 2025
Mon Jul 21 05:16:13 EDT 2025
Thu Apr 24 23:10:09 EDT 2025
Tue Jul 01 02:43:36 EDT 2025
Fri Feb 23 02:27:40 EST 2024
Sun Feb 23 10:19:44 EST 2025
Tue Aug 26 16:33:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-b19f75f5ee0b7bf05a7a5f0f2167bbbfa60e0c849999c69cc2e66121454c53483
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S0301472X12001865
PMID 22659388
PQID 1033536846
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1033536846
pubmed_primary_22659388
crossref_primary_10_1016_j_exphem_2012_05_011
crossref_citationtrail_10_1016_j_exphem_2012_05_011
elsevier_sciencedirect_doi_10_1016_j_exphem_2012_05_011
elsevier_clinicalkeyesjournals_1_s2_0_S0301472X12001865
elsevier_clinicalkey_doi_10_1016_j_exphem_2012_05_011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-09-01
PublicationDateYYYYMMDD 2012-09-01
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Experimental hematology
PublicationTitleAlternate Exp Hematol
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Huang da, Sherman, Lempicki (bib25) 2009; 4
Fernandez-Luna (bib28) 1999; 6
Berkofsky-Fessler, Buzzai, Kim (bib17) 2010; 16
Quintas-Cardama, Verstovsek (bib39) 2011; 20
Pettit, Lewis, Nicholas (bib27) 1979; 43
Jensen, de Nully, Lund, Nielsen, Hasselbalch (bib41) 2000; 110
Skov, Larsen, Thomassen, Riley (bib21) 2011; 87
Thiele, Kvasnicka (bib2) 2006; 47
Vardiman, Thiele, Arber (bib5) 2009; 114
Kiladjian, Mesa, Hoffman (bib34) 2011; 117
Tefferi (bib11) 2010; 24
Jensen, de Nully, Lund, Nielsen, Hasselbalch (bib42) 2001; 66
Kristinsson, Landgren, Samuelsson, Bjorkholm, Goldin (bib49) 2010; 95
Wilkins, Erber, Bareford (bib3) 2008; 111
Gnatenko, Zhu, Xu (bib22) 2010; 115
Srebrow, Kornblihtt (bib48) 2006; 119
Lu, Wang, Li (bib31) 2010; 116
Larsen, Pallisgaard, Moller, Hasselbalch (bib9) 2007; 79
Guglielmelli, Zini, Bogani (bib14) 2007; 25
Quintas-Cardama, Kantarjian, Manshouri (bib33) 2009; 27
Tefferi (bib37) 2005; 23
Barbui, Carobbio, Finazzi (bib45) 2011; 96
Skov, Larsen, Thomassen (bib20) 2012; 53
Venables (bib47) 2004; 64
Barbui, Thiele, Passamonti (bib4) 2011; 29
Lu, Zhang, Li (bib36) 2010; 38
Huang da, Sherman, Lempicki (bib26) 2009; 37
Desterke, Bilhou-Nabera, Guerton (bib38) 2011; 71
Puigdecanet, Espinet, Lozano (bib12) 2008; 22
Pellagatti, Vetrie, Langford (bib13) 2003; 63
Harrison, Cramer (bib43) 1993; 7
Kralovics, Teo, Buser (bib15) 2005; 106
Campbell, Green (bib10) 2006; 355
Catani, Zini, Sollazzo (bib18) 2009; 23
DAMESHEK (bib1) 1951; 6
Wernig, Mercher, Okabe, Levine, Lee, Gilliland (bib6) 2006; 107
Falanga, Marchetti, Vignoli (bib44) 2007; 35
Ghigna, Valacca, Biamonti (bib46) 2008; 9
Tiedt, Hao-Shen, Sobas (bib7) 2008; 111
Larsen, Moller, de Stricker (bib35) 2009; 14
Jones, Tefferi, Vuong, Desmond, Hofmann, Koeffler (bib16) 2005; 23
Li, Wong (bib24) 2001; 2
Will, Siddiqi, Jorda (bib30) 2010; 115
Kiladjian, Cassinat, Chevret (bib32) 2008; 112
Hasselbalch, Skov, Larsen (bib19) 2011 Oct; 35
Silva, Richard, Benito, Sanz, Olalla, Fernandez-Luna (bib29) 1998; 338
Larsen, Christensen, Hasselbalch, Pallisgaard (bib23) 2007; 136
Falanga, Marchetti, Vignoli, Balducci, Barbui (bib40) 2005; 33
Vannucchi, Pancrazzi, Bogani, Antonioli, Guglielmelli (bib8) 2006; 20
Plo, Nakatake, Malivert (bib50) 2008; 112
Wernig (10.1016/j.exphem.2012.05.011_bib6) 2006; 107
Larsen (10.1016/j.exphem.2012.05.011_bib9) 2007; 79
Jones (10.1016/j.exphem.2012.05.011_bib16) 2005; 23
Harrison (10.1016/j.exphem.2012.05.011_bib43) 1993; 7
Plo (10.1016/j.exphem.2012.05.011_bib50) 2008; 112
DAMESHEK (10.1016/j.exphem.2012.05.011_bib1) 1951; 6
Kristinsson (10.1016/j.exphem.2012.05.011_bib49) 2010; 95
Falanga (10.1016/j.exphem.2012.05.011_bib40) 2005; 33
Guglielmelli (10.1016/j.exphem.2012.05.011_bib14) 2007; 25
Skov (10.1016/j.exphem.2012.05.011_bib21) 2011; 87
Pellagatti (10.1016/j.exphem.2012.05.011_bib13) 2003; 63
Kralovics (10.1016/j.exphem.2012.05.011_bib15) 2005; 106
Jensen (10.1016/j.exphem.2012.05.011_bib41) 2000; 110
Venables (10.1016/j.exphem.2012.05.011_bib47) 2004; 64
Kiladjian (10.1016/j.exphem.2012.05.011_bib32) 2008; 112
Lu (10.1016/j.exphem.2012.05.011_bib36) 2010; 38
Barbui (10.1016/j.exphem.2012.05.011_bib4) 2011; 29
Quintas-Cardama (10.1016/j.exphem.2012.05.011_bib39) 2011; 20
Kiladjian (10.1016/j.exphem.2012.05.011_bib34) 2011; 117
Larsen (10.1016/j.exphem.2012.05.011_bib23) 2007; 136
Falanga (10.1016/j.exphem.2012.05.011_bib44) 2007; 35
Wilkins (10.1016/j.exphem.2012.05.011_bib3) 2008; 111
Jensen (10.1016/j.exphem.2012.05.011_bib42) 2001; 66
Ghigna (10.1016/j.exphem.2012.05.011_bib46) 2008; 9
Desterke (10.1016/j.exphem.2012.05.011_bib38) 2011; 71
Barbui (10.1016/j.exphem.2012.05.011_bib45) 2011; 96
Vannucchi (10.1016/j.exphem.2012.05.011_bib8) 2006; 20
Skov (10.1016/j.exphem.2012.05.011_bib20) 2012; 53
Hasselbalch (10.1016/j.exphem.2012.05.011_bib19) 2011; 35
Campbell (10.1016/j.exphem.2012.05.011_bib10) 2006; 355
Catani (10.1016/j.exphem.2012.05.011_bib18) 2009; 23
Tiedt (10.1016/j.exphem.2012.05.011_bib7) 2008; 111
Thiele (10.1016/j.exphem.2012.05.011_bib2) 2006; 47
Larsen (10.1016/j.exphem.2012.05.011_bib35) 2009; 14
Vardiman (10.1016/j.exphem.2012.05.011_bib5) 2009; 114
Srebrow (10.1016/j.exphem.2012.05.011_bib48) 2006; 119
Fernandez-Luna (10.1016/j.exphem.2012.05.011_bib28) 1999; 6
Lu (10.1016/j.exphem.2012.05.011_bib31) 2010; 116
Huang da (10.1016/j.exphem.2012.05.011_bib26) 2009; 37
Puigdecanet (10.1016/j.exphem.2012.05.011_bib12) 2008; 22
Berkofsky-Fessler (10.1016/j.exphem.2012.05.011_bib17) 2010; 16
Tefferi (10.1016/j.exphem.2012.05.011_bib37) 2005; 23
Li (10.1016/j.exphem.2012.05.011_bib24) 2001; 2
Tefferi (10.1016/j.exphem.2012.05.011_bib11) 2010; 24
Quintas-Cardama (10.1016/j.exphem.2012.05.011_bib33) 2009; 27
Silva (10.1016/j.exphem.2012.05.011_bib29) 1998; 338
Pettit (10.1016/j.exphem.2012.05.011_bib27) 1979; 43
Huang da (10.1016/j.exphem.2012.05.011_bib25) 2009; 4
Gnatenko (10.1016/j.exphem.2012.05.011_bib22) 2010; 115
Will (10.1016/j.exphem.2012.05.011_bib30) 2010; 115
References_xml – volume: 24
  start-page: 1128
  year: 2010
  end-page: 1138
  ident: bib11
  article-title: Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
  publication-title: Leukemia
– volume: 79
  start-page: 508
  year: 2007
  end-page: 515
  ident: bib9
  article-title: The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis—impact on disease phenotype
  publication-title: Eur J Haematol
– volume: 7
  start-page: 52
  year: 1993
  end-page: 62
  ident: bib43
  article-title: Platelet alpha-granules
  publication-title: Blood Rev
– volume: 64
  start-page: 7647
  year: 2004
  end-page: 7654
  ident: bib47
  article-title: Aberrant and alternative splicing in cancer
  publication-title: Cancer Res
– volume: 115
  start-page: 2901
  year: 2010
  end-page: 2909
  ident: bib30
  article-title: Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells
  publication-title: Blood
– volume: 22
  start-page: 1368
  year: 2008
  end-page: 1376
  ident: bib12
  article-title: Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia
  publication-title: Leukemia
– volume: 71
  start-page: 2901
  year: 2011
  end-page: 2915
  ident: bib38
  article-title: FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis
  publication-title: Cancer Res
– volume: 96
  start-page: 315
  year: 2011
  end-page: 318
  ident: bib45
  article-title: Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
  publication-title: Haematologica
– volume: 6
  start-page: 372
  year: 1951
  end-page: 375
  ident: bib1
  article-title: Some speculations on the myeloproliferative syndromes
  publication-title: Blood
– volume: 23
  start-page: 997
  year: 2009
  end-page: 1000
  ident: bib18
  article-title: Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia
  publication-title: Leukemia
– volume: 23
  start-page: 8520
  year: 2005
  end-page: 8530
  ident: bib37
  article-title: Pathogenesis of myelofibrosis with myeloid metaplasia
  publication-title: J Clin Oncol
– volume: 119
  start-page: 2635
  year: 2006
  end-page: 2641
  ident: bib48
  article-title: The connection between splicing and cancer
  publication-title: J Cell Sci
– volume: 136
  start-page: 745
  year: 2007
  end-page: 751
  ident: bib23
  article-title: The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders
  publication-title: Br J Haematol
– volume: 338
  start-page: 564
  year: 1998
  end-page: 571
  ident: bib29
  article-title: Expression of Bcl-x in erythroid precursors from patients with polycythemia vera
  publication-title: N Engl J Med
– volume: 110
  start-page: 116
  year: 2000
  end-page: 124
  ident: bib41
  article-title: Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders
  publication-title: Br J Haematol
– volume: 111
  start-page: 60
  year: 2008
  end-page: 70
  ident: bib3
  article-title: Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
  publication-title: Blood
– volume: 111
  start-page: 3931
  year: 2008
  end-page: 3940
  ident: bib7
  article-title: Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
  publication-title: Blood
– volume: 38
  start-page: 472
  year: 2010
  end-page: 480
  ident: bib36
  article-title: Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
  publication-title: Exp Hematol
– volume: 23
  start-page: 631
  year: 2005
  end-page: 637
  ident: bib16
  article-title: Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays
  publication-title: Stem Cells
– volume: 16
  start-page: 4339
  year: 2010
  end-page: 4352
  ident: bib17
  article-title: Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F
  publication-title: Clin Cancer Res
– volume: 106
  start-page: 3374
  year: 2005
  end-page: 3376
  ident: bib15
  article-title: Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
  publication-title: Blood
– volume: 95
  start-page: 1216
  year: 2010
  end-page: 1220
  ident: bib49
  article-title: Autoimmunity and the risk of myeloproliferative neoplasms
  publication-title: Haematologica
– volume: 63
  start-page: 3940
  year: 2003
  end-page: 3944
  ident: bib13
  article-title: Gene expression profiling in polycythemia vera using cDNA microarray technology
  publication-title: Cancer Res
– volume: 112
  start-page: 3065
  year: 2008
  end-page: 3072
  ident: bib32
  article-title: Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
  publication-title: Blood
– volume: 37
  start-page: 1
  year: 2009
  end-page: 13
  ident: bib26
  article-title: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
  publication-title: Nucleic Acids Res
– volume: 20
  start-page: 961
  year: 2011
  end-page: 972
  ident: bib39
  article-title: New JAK2 inhibitors for myeloproliferative neoplasms
  publication-title: Expert Opin Investig Drugs
– volume: 35
  start-page: 1330
  year: 2011 Oct
  end-page: 1334
  ident: bib19
  article-title: High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis
  publication-title: Leuk Res
– volume: 116
  start-page: 4284
  year: 2010
  end-page: 4287
  ident: bib31
  article-title: Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon alpha specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells
  publication-title: Blood
– volume: 43
  start-page: 167
  year: 1979
  end-page: 184
  ident: bib27
  article-title: Transitional myeloproliferative disorder
  publication-title: Br J Haematol
– volume: 6
  start-page: 94
  year: 1999
  end-page: 99
  ident: bib28
  article-title: Apoptosis and polycythemia vera
  publication-title: Curr Opin Hematol
– volume: 27
  start-page: 5418
  year: 2009
  end-page: 5424
  ident: bib33
  article-title: Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera
  publication-title: J Clin Oncol
– volume: 2
  start-page: 1
  year: 2001
  end-page: 11
  ident: bib24
  article-title: Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application
  publication-title: Genome Biol
– volume: 20
  start-page: 1055
  year: 2006
  end-page: 1060
  ident: bib8
  article-title: A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
  publication-title: Leukemia
– volume: 35
  start-page: 702
  year: 2007
  end-page: 711
  ident: bib44
  article-title: V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules
  publication-title: Exp Hematol
– volume: 47
  start-page: 381
  year: 2006
  end-page: 396
  ident: bib2
  article-title: A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders
  publication-title: Leuk Lymphoma
– volume: 115
  start-page: 7
  year: 2010
  end-page: 14
  ident: bib22
  article-title: Class prediction models of thrombocytosis using genetic biomarkers
  publication-title: Blood
– volume: 114
  start-page: 937
  year: 2009
  end-page: 951
  ident: bib5
  article-title: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
  publication-title: Blood
– volume: 355
  start-page: 2452
  year: 2006
  end-page: 2466
  ident: bib10
  article-title: The myeloproliferative disorders
  publication-title: N Engl J Med
– volume: 25
  start-page: 165
  year: 2007
  end-page: 173
  ident: bib14
  article-title: Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)
  publication-title: Stem Cells
– volume: 14
  start-page: 331
  year: 2009
  end-page: 334
  ident: bib35
  article-title: Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
  publication-title: Hematology
– volume: 87
  start-page: 54
  year: 2011
  end-page: 60
  ident: bib21
  article-title: Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
  publication-title: Eur J Haematol
– volume: 9
  start-page: 556
  year: 2008
  end-page: 570
  ident: bib46
  article-title: Alternative splicing and tumor progression
  publication-title: Curr Genomics
– volume: 107
  start-page: 4274
  year: 2006
  end-page: 4281
  ident: bib6
  article-title: Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
  publication-title: Blood
– volume: 66
  start-page: 143
  year: 2001
  end-page: 151
  ident: bib42
  article-title: Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count
  publication-title: Eur J Haematol
– volume: 53
  start-page: 123
  year: 2012
  end-page: 129
  ident: bib20
  article-title: Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms
  publication-title: Leuk Lymphoma
– volume: 29
  start-page: 3179
  year: 2011
  end-page: 3184
  ident: bib4
  article-title: Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study
  publication-title: J Clin Oncol
– volume: 4
  start-page: 44
  year: 2009
  end-page: 57
  ident: bib25
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
  publication-title: Nat Protoc
– volume: 112
  start-page: 1402
  year: 2008
  end-page: 1412
  ident: bib50
  article-title: JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
  publication-title: Blood
– volume: 117
  start-page: 4706
  year: 2011
  end-page: 4715
  ident: bib34
  article-title: The renaissance of interferon therapy for the treatment of myeloid malignancies
  publication-title: Blood
– volume: 33
  start-page: 523
  year: 2005
  end-page: 530
  ident: bib40
  article-title: Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera
  publication-title: Exp Hematol
– volume: 47
  start-page: 381
  year: 2006
  ident: 10.1016/j.exphem.2012.05.011_bib2
  article-title: A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428190500331329
– volume: 27
  start-page: 5418
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib33
  article-title: Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.23.6075
– volume: 64
  start-page: 7647
  year: 2004
  ident: 10.1016/j.exphem.2012.05.011_bib47
  article-title: Aberrant and alternative splicing in cancer
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-1910
– volume: 63
  start-page: 3940
  year: 2003
  ident: 10.1016/j.exphem.2012.05.011_bib13
  article-title: Gene expression profiling in polycythemia vera using cDNA microarray technology
  publication-title: Cancer Res
– volume: 112
  start-page: 1402
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib50
  article-title: JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
  publication-title: Blood
  doi: 10.1182/blood-2008-01-134114
– volume: 37
  start-page: 1
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib26
  article-title: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkn923
– volume: 112
  start-page: 3065
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib32
  article-title: Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
  publication-title: Blood
  doi: 10.1182/blood-2008-03-143537
– volume: 33
  start-page: 523
  year: 2005
  ident: 10.1016/j.exphem.2012.05.011_bib40
  article-title: Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2005.01.015
– volume: 96
  start-page: 315
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib45
  article-title: Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
  publication-title: Haematologica
  doi: 10.3324/haematol.2010.031070
– volume: 35
  start-page: 702
  year: 2007
  ident: 10.1016/j.exphem.2012.05.011_bib44
  article-title: V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2007.01.053
– volume: 95
  start-page: 1216
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib49
  article-title: Autoimmunity and the risk of myeloproliferative neoplasms
  publication-title: Haematologica
  doi: 10.3324/haematol.2009.020412
– volume: 79
  start-page: 508
  year: 2007
  ident: 10.1016/j.exphem.2012.05.011_bib9
  article-title: The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis—impact on disease phenotype
  publication-title: Eur J Haematol
  doi: 10.1111/j.1600-0609.2007.00960.x
– volume: 355
  start-page: 2452
  year: 2006
  ident: 10.1016/j.exphem.2012.05.011_bib10
  article-title: The myeloproliferative disorders
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra063728
– volume: 2
  start-page: 1
  year: 2001
  ident: 10.1016/j.exphem.2012.05.011_bib24
  article-title: Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application
  publication-title: Genome Biol
  doi: 10.1186/gb-2001-2-8-research0032
– volume: 106
  start-page: 3374
  year: 2005
  ident: 10.1016/j.exphem.2012.05.011_bib15
  article-title: Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
  publication-title: Blood
  doi: 10.1182/blood-2005-05-1889
– volume: 119
  start-page: 2635
  year: 2006
  ident: 10.1016/j.exphem.2012.05.011_bib48
  article-title: The connection between splicing and cancer
  publication-title: J Cell Sci
  doi: 10.1242/jcs.03053
– volume: 6
  start-page: 372
  year: 1951
  ident: 10.1016/j.exphem.2012.05.011_bib1
  article-title: Some speculations on the myeloproliferative syndromes
  publication-title: Blood
  doi: 10.1182/blood.V6.4.372.372
– volume: 66
  start-page: 143
  year: 2001
  ident: 10.1016/j.exphem.2012.05.011_bib42
  article-title: Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count
  publication-title: Eur J Haematol
  doi: 10.1034/j.1600-0609.2001.00359.x
– volume: 110
  start-page: 116
  year: 2000
  ident: 10.1016/j.exphem.2012.05.011_bib41
  article-title: Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2000.02030.x
– volume: 117
  start-page: 4706
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib34
  article-title: The renaissance of interferon therapy for the treatment of myeloid malignancies
  publication-title: Blood
  doi: 10.1182/blood-2010-08-258772
– volume: 9
  start-page: 556
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib46
  article-title: Alternative splicing and tumor progression
  publication-title: Curr Genomics
  doi: 10.2174/138920208786847971
– volume: 115
  start-page: 2901
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib30
  article-title: Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells
  publication-title: Blood
  doi: 10.1182/blood-2009-03-209544
– volume: 71
  start-page: 2901
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib38
  article-title: FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-1731
– volume: 29
  start-page: 3179
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib4
  article-title: Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.34.5298
– volume: 114
  start-page: 937
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib5
  article-title: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
  publication-title: Blood
  doi: 10.1182/blood-2009-03-209262
– volume: 20
  start-page: 1055
  year: 2006
  ident: 10.1016/j.exphem.2012.05.011_bib8
  article-title: A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404209
– volume: 23
  start-page: 8520
  year: 2005
  ident: 10.1016/j.exphem.2012.05.011_bib37
  article-title: Pathogenesis of myelofibrosis with myeloid metaplasia
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.00.9316
– volume: 16
  start-page: 4339
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib17
  article-title: Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-10-1092
– volume: 25
  start-page: 165
  year: 2007
  ident: 10.1016/j.exphem.2012.05.011_bib14
  article-title: Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1)
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2006-0351
– volume: 7
  start-page: 52
  year: 1993
  ident: 10.1016/j.exphem.2012.05.011_bib43
  article-title: Platelet alpha-granules
  publication-title: Blood Rev
  doi: 10.1016/0268-960X(93)90024-X
– volume: 107
  start-page: 4274
  year: 2006
  ident: 10.1016/j.exphem.2012.05.011_bib6
  article-title: Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model
  publication-title: Blood
  doi: 10.1182/blood-2005-12-4824
– volume: 111
  start-page: 3931
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib7
  article-title: Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
  publication-title: Blood
  doi: 10.1182/blood-2007-08-107748
– volume: 23
  start-page: 997
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib18
  article-title: Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia
  publication-title: Leukemia
  doi: 10.1038/leu.2008.357
– volume: 20
  start-page: 961
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib39
  article-title: New JAK2 inhibitors for myeloproliferative neoplasms
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.2011.579560
– volume: 43
  start-page: 167
  year: 1979
  ident: 10.1016/j.exphem.2012.05.011_bib27
  article-title: Transitional myeloproliferative disorder
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.1979.tb03739.x
– volume: 22
  start-page: 1368
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib12
  article-title: Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia
  publication-title: Leukemia
  doi: 10.1038/leu.2008.112
– volume: 53
  start-page: 123
  year: 2012
  ident: 10.1016/j.exphem.2012.05.011_bib20
  article-title: Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428194.2011.597905
– volume: 23
  start-page: 631
  year: 2005
  ident: 10.1016/j.exphem.2012.05.011_bib16
  article-title: Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2004-0131
– volume: 24
  start-page: 1128
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib11
  article-title: Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
  publication-title: Leukemia
  doi: 10.1038/leu.2010.69
– volume: 87
  start-page: 54
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib21
  article-title: Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
  publication-title: Eur J Haematol
  doi: 10.1111/j.1600-0609.2011.01618.x
– volume: 111
  start-page: 60
  year: 2008
  ident: 10.1016/j.exphem.2012.05.011_bib3
  article-title: Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
  publication-title: Blood
  doi: 10.1182/blood-2007-05-091850
– volume: 14
  start-page: 331
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib35
  article-title: Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
  publication-title: Hematology
  doi: 10.1179/102453309X12473408860587
– volume: 115
  start-page: 7
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib22
  article-title: Class prediction models of thrombocytosis using genetic biomarkers
  publication-title: Blood
  doi: 10.1182/blood-2009-05-224477
– volume: 35
  start-page: 1330
  issue: 10
  year: 2011
  ident: 10.1016/j.exphem.2012.05.011_bib19
  article-title: High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis
  publication-title: Leuk Res
  doi: 10.1016/j.leukres.2011.03.013
– volume: 4
  start-page: 44
  year: 2009
  ident: 10.1016/j.exphem.2012.05.011_bib25
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2008.211
– volume: 6
  start-page: 94
  year: 1999
  ident: 10.1016/j.exphem.2012.05.011_bib28
  article-title: Apoptosis and polycythemia vera
  publication-title: Curr Opin Hematol
  doi: 10.1097/00062752-199903000-00007
– volume: 38
  start-page: 472
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib36
  article-title: Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
  publication-title: Exp Hematol
  doi: 10.1016/j.exphem.2010.03.005
– volume: 116
  start-page: 4284
  year: 2010
  ident: 10.1016/j.exphem.2012.05.011_bib31
  article-title: Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon alpha specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells
  publication-title: Blood
  doi: 10.1182/blood-2010-04-279125
– volume: 338
  start-page: 564
  year: 1998
  ident: 10.1016/j.exphem.2012.05.011_bib29
  article-title: Expression of Bcl-x in erythroid precursors from patients with polycythemia vera
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199802263380902
– volume: 136
  start-page: 745
  year: 2007
  ident: 10.1016/j.exphem.2012.05.011_bib23
  article-title: The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2007.06497.x
SSID ssj0005590
Score 2.2724085
Snippet The recent discovery of the Janus activating kinase 2 V617F mutation in most patients with polycythemia vera (PV) and half of those with essential...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 771
SubjectTerms Adult
Advanced Basic Science
Aged
Aged, 80 and over
Cluster Analysis
Female
Gene Expression Profiling - statistics & numerical data
Hematology, Oncology, and Palliative Medicine
Humans
Janus Kinase 2 - genetics
Male
Middle Aged
Oligonucleotide Array Sequence Analysis - statistics & numerical data
Polycythemia Vera - genetics
Polycythemia Vera - pathology
Primary Myelofibrosis - genetics
Primary Myelofibrosis - pathology
Principal Component Analysis
Thrombocythemia, Essential - genetics
Thrombocythemia, Essential - pathology
Title Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0301472X12001865
https://www.clinicalkey.es/playcontent/1-s2.0-S0301472X12001865
https://dx.doi.org/10.1016/j.exphem.2012.05.011
https://www.ncbi.nlm.nih.gov/pubmed/22659388
https://www.proquest.com/docview/1033536846
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_HCeKL-O16ekTwtW7bJE37eCwe68cdoh7sW0jSBCu7bbFduH3xn_EfdaZplxM9TnwqTZOm6UwyvyS_mRDySpa81IAcorL0PuIAWaNCSxnxLE-043lZDtsFZ-fZ8oK_W4nVAVlMvjBIqxzH_jCmD6P1mDIf_-a8rar552E2INNVgrSgPENHc84lavnrH1doHiKss0DmCHNP7nMDx8tdtl8d-qPjiiDG70yuM0_Xwc_BDJ3eI3dH_EhPwifeJweufkBun4075A_JT4wjTaHGwG-taTiUGwwUxSVX2obFdXgFksmbGmwO1WNgElq6trJ9RwEU0hCdCUVIkc5e1dvthqIzCsVo45AAD_CMhY1p7A5Dv1aaIh2Uts16t0-BBE37hm52bg3fYaDRVfeIXJy--bJYRuNBDJHlMu4jkxReCi-ci400PhZaauFjnyaZNMZ4ncUutjlOngqbFdamLsPIZFxwKxjP2WNyWEOLnhKqjZelS5xzGUzKfZrbAjCeTHTKtGAFmxE2_X9lxyjleFjGWk10tG8qSE2h1FQsFEhtRqJ9qTZE6bghv5hEqyYPVBgzFZiRG8rJv5Vz3djxO5WoDjKrP5Tzasnf9Psf6nw56Z6Cro_7Obp2zRbqihkTLAMEOSNPglLuWw-oWhQsz5_9d71H5A7eBT7dc3LYf9-6FwDAenM89LBjcutk8enDR7y-fb88_wV10zbD
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9wgEEbpRmp7qfru9kmlXq31C2Mfo6jRpsnupYm0NwQYVEe7tlV7pezvyR_tjMHbVm2UqldgjGGAGeCbD0I-8TItJXgOQVlaG6TgsgaF5DxIszySJs3LcrguWCyz-WX6ZcVWB-R4jIVBWKVf-92aPqzWPmXme3PWVtXs67Ab4PEqQlhQnrF75BDZqdiEHB6dns2XP5EezB21QPkABcYIugHmZa7bbwZD0vFQECk8o9ss1G0e6GCJTh6TR96FpEfuL5-QA1M_JfcX_pL8GblBKmkKNTqIa03du9xgoyieutLWna_DJxBP3tRgdqj03CS0NG2l-46CX0gdQRNqkSKivaq32w3FeBSKhOOQABn4zMJGNXqH7K-VpIgIpW2z3u1TIEHSvqGbnVnDfyhodNU9J5cnny-O54F_iyHQKQ_7QEWF5cwyY0LFlQ2Z5JLZ0MZRxpVSVmahCXWO-6dCZ4XWscmQnAw0olmS5skLMqmhRa8Ilcry0kTGmAz25TbOdQFuHo9knEiWFMmUJGP_C-2JyvG9jLUYEWlXwmlNoNZEyARobUqCvVTriDruKM9G1YoxCBWWTQGW5A45_jc50_m534lIdFBY_DE-f5X8bYj_Q50fx7EnYPbjlY6sTbOFusIkYUkGTuSUvHSDct96cKxZkeT56_-u9wN5ML9YnIvz0-XZG_IQcxy87i2Z9N-35h34Y7167-fbDzVIN98
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+expression+profiling+with+principal+component+analysis+depicts+the+biological+continuum+from+essential+thrombocythemia+over+polycythemia+vera+to+myelofibrosis&rft.jtitle=Experimental+hematology&rft.au=Skov%2C+Vibe&rft.au=Thomassen%2C+Mads&rft.au=Riley%2C+Caroline+H&rft.au=Jensen%2C+Morten+K&rft.date=2012-09-01&rft.issn=0301-472X&rft.volume=40&rft.issue=9&rft.spage=771&rft.epage=780.e19&rft_id=info:doi/10.1016%2Fj.exphem.2012.05.011&rft.externalDBID=ECK1-s2.0-S0301472X12001865&rft.externalDocID=1_s2_0_S0301472X12001865
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0301472X%2FS0301472X11X00218%2Fcov150h.gif